LETKO BROSSEAU & ASSOCIATES INC 13D and 13G filings for Profound Medical Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-11 09:42 am Purchase | 2024-09-30 | 13G | Profound Medical Corp. PROF | LETKO BROSSEAU & ASSOCIATES INC | 1,198,775 4.900% | 20,925 (+1.78%) | Filing |
| 2024-02-12 2:37 pm Sale | 2023-12-31 | 13G | Profound Medical Corp. PROF | LETKO BROSSEAU & ASSOCIATES INC | 1,177,850 5.500% | -2,575 (-0.22%) | Filing |
| 2023-02-09 5:42 pm Purchase | 2022-12-31 | 13G | Profound Medical Corp. PROF | LETKO BROSSEAU & ASSOCIATES INC | 1,180,425 5.700% | 1,180,425 (New Position) | Filing |